A Prospective Trial of an Endoscopic Quality Improvement Project

A Prospective Randomized Controlled Trial of an Endoscopic Quality Improvement Project-2 (EQUIP-2) to Improve Adenoma Detection in Screening and Surveillance Colonoscopy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02325635

Acronym

Equip 2

Enrollment

Registered

2014-12-25

Start date

2013-11-30

Completion date

2015-09-30

Last updated

2015-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Polyps

Keywords

Adenoma Detection, Adenoma Prediction

Brief summary

Randomized prospective multi-site validation study.

Detailed description

GI practice sites that have recently agreed to participate in the GIQuIC program will be randomized on a site-basis, to the EQUIP intervention or control. Baseline ADR and polyp/surveillance predication accuracy will be collected for approximately 3 months. Sites randomized to the EQUIP intervention will undergo face-to-face training by a study investigator, followed by active monitoring and feedback. Control sites will not receive supplemental training and will be monitored by with no feedback. After completion of the study all sites will be offered the intervention (as is standard feedback in GIQuIC ).

Interventions

OTHEREducational Training

Intervention/Training offered to endoscopists only.

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Endoscopy centers that are new to GIQuIC and have not yet received training * All endoscopists performing screening and surveillance colonoscopy at the participating center will be invited to participate

Exclusion criteria

* Cases that involve acute indications such as bleeding and active colitis will not be included in data pool * Patients with a family or personal history of a polyposis syndrome or with a personal history of inflammatory bowel disease will also be excluded * Procedures that are deemed incomplete will be excluded * Patients with surgically altered anatomy (i.e. prior colectomy) and with poor bowel preparation (Boston bowel preparation score \<5, or inadequate to exclude polyps \>5mm) will be excluded

Design outcomes

Primary

Measure	Time frame	Description
Change in adenoma detection rates.	6 months	The primary outcome will be the change in adenoma detection rates between baseline and the intervention. Validate the effect of a quality improvement training program on the proportion of patients among whom at least one adenoma is detected

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026